Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways (2013)

  • Authors:
  • USP affiliated authors: SCHMIDT, ANDRE - FMRP ; MARIN NETO, JOSE ANTONIO - FMRP ; HIRATA, MARIO HIROYUKI - FCF ; DONADI, EDUARDO ANTONIO - FMRP ; KALIL FILHO, JORGE ELIAS - FM ; CUNHA NETO, EDECIO - FM
  • USP Schools: FMRP; FMRP; FCF; FMRP; FM; FM
  • DOI: 10.1186/1471-2334-13-587
  • Subjects: DOENÇA DE CHAGAS; MIOCARDIOPATIA CHAGÁSICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/1471-2334-13-587 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: bronze
    • Licença: cc-by
    Informações sobre o Citescore
  • Título: BMC Infectious Diseases

    ISSN: 1471-2334

    Citescore - 2017: 2.86

    SJR - 2017: 1.576

    SNIP - 2017: 1.187


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2442268-10BCSEP 122 2013
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FRADE, Amanda Farage; PISSSETTI, Cristina Wide; IANNI, Barbara Maria; et al. Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. BMC Infectious Diseases, London, v. 13, p. 587, 2013. Disponível em: < http://dx.doi.org/10.1186/1471-2334-13-587 > DOI: 10.1186/1471-2334-13-587.
    • APA

      Frade, A. F., Pisssetti, C. W., Ianni, B. M., Saba, B., Wang, H. T. L., Nogueira, L. G., et al. (2013). Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. BMC Infectious Diseases, 13, 587. doi:10.1186/1471-2334-13-587
    • NLM

      Frade AF, Pisssetti CW, Ianni BM, Saba B, Wang HTL, Nogueira LG, Borges A de M, Buck P, Dias F, Baron M, Ferreira LRP, Schmidt A, Marin Neto JA, Hirata MH, Sampaio M, Fragata A, Pereira AC, Donadi EA, Kalil Filho JE, Rodrigues V, Cunha Neto E, Chevillard C. Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways [Internet]. BMC Infectious Diseases. 2013 ; 13 587.Available from: http://dx.doi.org/10.1186/1471-2334-13-587
    • Vancouver

      Frade AF, Pisssetti CW, Ianni BM, Saba B, Wang HTL, Nogueira LG, Borges A de M, Buck P, Dias F, Baron M, Ferreira LRP, Schmidt A, Marin Neto JA, Hirata MH, Sampaio M, Fragata A, Pereira AC, Donadi EA, Kalil Filho JE, Rodrigues V, Cunha Neto E, Chevillard C. Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways [Internet]. BMC Infectious Diseases. 2013 ; 13 587.Available from: http://dx.doi.org/10.1186/1471-2334-13-587

    Referências citadas na obra
    Schofield CJ, Jannin J, Salvatella R: The future of Chagas disease control. Trends Parasitol. 2006, 22 (12): 583-588. 10.1016/j.pt.2006.09.011.
    Coura JR: Chagas disease: what is known and what is needed–a background article. Mem Inst Oswaldo Cruz. 2007, 102 (Suppl 1): 113-122.
    Kirchhoff LV, Weiss LM, Wittner M, Tanowitz HB: Parasitic diseases of the heart. Front Biosci. 2004, 9: 706-723. 10.2741/1255.
    Barbosa AP, Cardinalli Neto A, Otaviano AP, Rocha BF, Bestetti RB: Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy. Arq Bras Cardiol. 2011, 97 (6): 517-525. 10.1590/S0066-782X2011005000112.
    Bestetti RB, Muccillo G: Clinical course of Chagas’ heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol. 1997, 60 (2): 187-193. 10.1016/S0167-5273(97)00083-1.
    Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A: Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol. 2006, 177 (6): 3515-3519.
    Reis MM, Higuchi Mde L, Benvenuti LA, Aiello VD, Gutierrez PS, Bellotti G, Pileggi F: An in situ quantitative immunohistochemical study of cytokines and IL-2R + in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol. 1997, 83 (2): 165-172. 10.1006/clin.1997.4335.
    Bilate AM, Cunha-Neto E: Chagas disease cardiomyopathy: current concepts of an old disease. Rev Inst Med Trop Sao Paulo. 2008, 50 (2): 67-74. 10.1590/S0036-46652008007500001.
    Muller U, Kohler G, Mossmann H, Schaub GA, Alber G, Di Santo JP, Brombacher F, Holscher C: IL-12-independent IFN-gamma production by T cells in experimental Chagas’ disease is mediated by IL-18. J Immunol. 2001, 167 (6): 3346-3353.
    Rocha Rodrigues DB, dos Reis MA, Romano A, Pereira SA, Teixeira Vde P, Tostes S, Rodrigues V: In situ expression of regulatory cytokines by heart inflammatory cells in Chagas’ disease patients with heart failure. Clin Dev Immunol. 2013, 2012: 361730-
    Ribeirao M, Pereira-Chioccola VL, Renia L, Augusto Fragata Filho A, Schenkman S, Rodrigues MM: Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol. 2000, 22 (1): 49-53. 10.1046/j.1365-3024.2000.00260.x.
    Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML, Koyama NS, Silva JS, Kalil J, Liew CC: Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas’ disease cardiomyopathy. Am J Pathol. 2005, 167 (2): 305-313. 10.1016/S0002-9440(10)62976-8.
    Cunha-Neto E, Kalil J: Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas’ disease cardiomyopathy. Autoimmunity. 2001, 34 (3): 187-192. 10.3109/08916930109007383.
    Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM: Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis. 2004, 38 (7): 943-950. 10.1086/381892.
    Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R: Evidence that development of severe cardiomyopathy in human Chagas’ disease is due to a Th1-specific immune response. Infect Immun. 2003, 71 (3): 1185-1193. 10.1128/IAI.71.3.1185-1193.2003.
    Talvani A, Rocha MO, Ribeiro AL, Correa-Oliveira R, Teixeira MM: Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis. 2004, 189 (2): 214-220. 10.1086/380803.
    Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, Morato MJ, Correa-Oliveira R: Potential role of CD4 + CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci. 2007, 12: 2797-2806. 10.2741/2273.
    Guedes PM, Gutierrez FR, Silva GK, Dellalibera-Joviliano R, Rodrigues GJ, Bendhack LM, Rassi A, Rassi A, Schmidt A, Maciel BC, et al: Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas’ disease. PLoS Negl Trop Dis. 2012, 6 (4): e1630-10.1371/journal.pntd.0001630.
    Magalhaes LM, Villani FN, Nunes Mdo C, Gollob KJ, Rocha MO, Dutra WO: High interleukin 17 expression is correlated with better cardiac function in human Chagas disease. J Infect Dis. 2013, 207 (4): 661-665. 10.1093/infdis/jis724.
    Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, Bocchi EA, Teixeira HC, Mady C, Kalil J, et al: Chronic Chagas’ disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun. 2001, 17 (1): 99-107. 10.1006/jaut.2001.0523.
    Reis DD, Jones EM, Tostes S, Lopes ER, Chapadeiro E, Gazzinelli G, Colley DG, McCurley TL: Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas’ disease. Am J Trop Med Hyg. 1993, 49 (2): 192-200.
    Nogueira LG, Santos RH, Ianni BM, Fiorelli AI, Mairena EC, Benvenuti LA, Frade A, Donadi E, Dias F, Saba B, et al: Myocardial Chemokine expression and intensity of myocarditis in Chagas cardiomyopathy Are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis. 2012, 6 (10): e1867-10.1371/journal.pntd.0001867.
    Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R: Type 1 chemokine receptor expression in Chagas’ disease correlates with morbidity in cardiac patients. Infect Immun. 2005, 73 (12): 7960-7966. 10.1128/IAI.73.12.7960-7966.2005.
    Zicker F, Smith PG, Netto JC, Oliveira RM, Zicker EM: Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas’ cardiopathy. Am J Trop Med Hyg. 1990, 43 (5): 498-505.
    Llop E, Rothhammer F, Acuna M, Apt W: HLA antigens in cardiomyopathic Chilean chagasics. Am J Hum Genet. 1988, 43 (5): 770-773.
    Llop E, Rothhammer F, Acuna M, Apt W, Arribada A: HLA antigens in Chagas cardiomyopathy: new evidence based on a case–control study. Rev Med Chil. 1991, 119 (6): 633-636.
    Fernandez-Mestre MT, Layrisse Z, Montagnani S, Acquatella H, Catalioti F, Matos M, Balbas O, Makhatadze N, Dominguez E, Herrera F, et al: Influence of the HLA class II polymorphism in chronic Chagas’ disease. Parasite Immunol. 1998, 20 (4): 197-203.
    Layrisse Z, Fernandez MT, Montagnani S, Matos M, Balbas O, Herrera F, Colorado IA, Catalioti F, Acquatella H: HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease. Hum Immunol. 2000, 61 (9): 925-929. 10.1016/S0198-8859(00)00161-0.
    Deghaide NH, Dantas RO, Donadi EA: HLA class I and II profiles of patients presenting with Chagas’ disease. Dig Dis Sci. 1998, 43 (2): 246-252. 10.1023/A:1018829600200.
    Colorado IA, Acquatella H, Catalioti F, Fernandez MT, Layrisse Z: HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum Immunol. 2000, 61 (3): 320-325. 10.1016/S0198-8859(99)00177-9.
    Rodriguez-Perez JM, Cruz-Robles D, Hernandez-Pacheco G, Perez-Hernandez N, Murguia LE, Granados J, Reyes PA, Vargas-Alarcon G: Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas’ disease. Immunol Lett. 2005, 98 (1): 97-102. 10.1016/j.imlet.2004.10.017.
    Campelo V, Dantas RO, Simoes RT, Mendes-Junior CT, Sousa SM, Simoes AL, Donadi EA: TNF microsatellite alleles in Brazilian Chagasic patients. Dig Dis Sci. 2007, 52 (12): 3334-3339. 10.1007/s10620-006-9699-7.
    Drigo SA, Cunha-Neto E, Ianni B, Mady C, Fae KC, Buck P, Kalil J, Goldberg AC: Lack of association of tumor necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients. Immunol Lett. 2007, 108 (1): 109-111. 10.1016/j.imlet.2006.10.008.
    Beraun Y, Nieto A, Collado MD, Gonzalez A, Martin J: Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas’ disease. Tissue Antigens. 1998, 52 (1): 81-83. 10.1111/j.1399-0039.1998.tb03028.x.
    Drigo SA, Cunha-Neto E, Ianni B, Cardoso MR, Braga PE, Fae KC, Nunes VL, Buck P, Mady C, Kalil J, et al: TNF gene polymorphisms are associated with reduced survival in severe Chagas’ disease cardiomyopathy patients. Microbes Infect. 2006, 8 (3): 598-603. 10.1016/j.micinf.2005.08.009.
    Florez O, Martin J, Gonzalez CI: Interleukin 4, interleukin 4 receptor-alpha and interleukin 10 gene polymorphisms in Chagas disease. Parasite Immunol. 2011, 33 (9): 506-511. 10.1111/j.1365-3024.2011.01314.x.
    Cruz-Robles D, Chavez-Gonzalez JP, Cavazos-Quero MM, Perez-Mendez O, Reyes PA, Vargas-Alarcon G: Association between IL-1B and IL-1RN gene polymorphisms and Chagas’ disease development susceptibility. Immunol Invest. 2009, 38 (3–4): 231-239.
    Costa GC, da Costa Rocha MO, Moreira PR, Menezes CA, Silva MR, Gollob KJ, Dutra WO: Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis. 2009, 199 (3): 451-454. 10.1086/596061.
    Moreno M, Silva EL, Ramirez LE, Palacio LG, Rivera D, Arcos-Burgos M: Chagas’ disease susceptibility/resistance: linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10. Tissue Antigens. 2004, 64 (1): 18-24. 10.1111/j.1399-0039.2004.00260.x.
    Zafra G, Morillo C, Martin J, Gonzalez A, Gonzalez CI: Polymorphism in the 3′ UTR of the IL12B gene is associated with Chagas’ disease cardiomyopathy. Microbes Infect. 2007, 9 (9): 1049-1052. 10.1016/j.micinf.2007.04.010.
    Ramasawmy R, Cunha-Neto E, Fae KC, Borba SC, Teixeira PC, Ferreira SC, Goldberg AC, Ianni B, Mady C, Kalil J: Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J Infect Dis. 2009, 199 (12): 1838-1845. 10.1086/599212.
    Ramasawmy R, Cunha-Neto E, Fae KC, Martello FG, Muller NG, Cavalcanti VL, Ianni B, Mady C, Kalil J, Goldberg AC: The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis. 2006, 43 (3): 305-311. 10.1086/505395.
    Ramasawmy R, Cunha-Neto E, Fae KC, Muller NG, Cavalcanti VL, Drigo SA, Ianni B, Mady C, Kalil J, Goldberg AC: BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis. 2006, 193 (10): 1394-1399. 10.1086/503368.
    Ramasawmy R, Fae KC, Cunha-Neto E, Muller NG, Cavalcanti VL, Ferreira RC, Drigo SA, Ianni B, Mady C, Goldberg AC, et al: Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy. J Infect Dis. 2007, 196 (12): 1836-1843. 10.1086/523653.
    Pissetti CW, de Oliveira RF, Correia D, Nascentes GA, Llaguno MM, Rodrigues V: Association between the lymphotoxin-alpha gene polymorphism and chagasic cardiopathy. J Interferon Cytokine Res. 2013, 33 (3): 130-135. 10.1089/jir.2012.0024.
    Ramasawmy R, Fae KC, Cunha-Neto E, Borba SC, Ianni B, Mady C, Goldberg AC, Kalil J: Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas’ cardiomyopathy among Trypanosoma cruzi-infected individuals. Mol Immunol. 2008, 45 (1): 283-288. 10.1016/j.molimm.2007.04.015.
    Calzada JE, Nieto A, Beraun Y, Martin J: Chemokine receptor CCR5 polymorphisms and Chagas’ disease cardiomyopathy. Tissue Antigens. 2001, 58 (3): 154-158. 10.1034/j.1399-0039.2001.580302.x.
    Fernandez-Mestre MT, Montagnani S, Layrisse Z: Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease?. Hum Immunol. 2004, 65 (7): 725-728. 10.1016/j.humimm.2004.05.002.
    Torres OA, Calzada JE, Beraun Y, Morillo CA, Gonzalez CI, Gonzalez A, Martin J: Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease. Hum Immunol. 2009, 70 (7): 543-546. 10.1016/j.humimm.2009.04.022.
    Torres OA, Calzada JE, Beraun Y, Morillo CA, Gonzalez A, Gonzalez CI, Martin J: Role of the IFNG +874 T/A polymorphism in Chagas disease in a Colombian population. Infect Genet Evol. 2010, 10 (5): 682-685. 10.1016/j.meegid.2010.03.009.
    Cunha-Neto E, Kalil J: Autoimmunity in Chagas’ heart disease. Sao Paulo Med J. 1995, 113 (2): 757-766.
    Teixeira PC, Frade AF, Nogueira LG, Kalil J, Chevillard C, Cunha-Neto E: Pathogenesis of Chagas disease cardiomyopathy. World J Clin Infect Dis. 2012, 2 (3): 39-53. 10.5495/wjcid.v2.i3.39.
    Vasconcelos RH, Montenegro SM, Azevedo EA, Gomes YM, Morais CN: Genetic susceptibility to chronic Chagas disease: an overview of single nucleotide polymorphisms of cytokine genes. Cytokine. 2012, 59 (2): 203-208. 10.1016/j.cyto.2012.04.035.
    Fae KC, Drigo SA, Cunha-Neto E, Ianni B, Mady C, Kalil J, Goldberg AC: HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy. Microbes Infect. 2000, 2 (7): 745-751. 10.1016/S1286-4579(00)00501-3.
    Weitzel T, Zulantay I, Danquah I, Hamann L, Schumann RR, Apt W, Mockenhaupt FP: Mannose-binding lectin and Toll-like receptor polymorphisms and Chagas disease in Chile. Am J Trop Med Hyg. 2012, 86 (2): 229-232. 10.4269/ajtmh.2012.11-0539.
    Jorge MT, Macedo TA, Janones RS, Carizzi DP, Heredia RA, Acha RE: Types of arrhythmia among cases of American trypanosomiasis, compared with those in other cardiology patients. Ann Trop Med Parasitol. 2003, 97 (2): 139-148. 10.1179/000349803235001561.
    van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL: B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013, 61 (14): 1498-1506. 10.1016/j.jacc.2012.12.044.
    Januzzi JL: Natriuretic peptides, ejection fraction, and prognosis: parsing the phenotypes of heart failure. J Am Coll Cardiol. 2013, 61 (14): 1507-1509. 10.1016/j.jacc.2013.01.039.
    Barretto AC, Arteaga E, Mady C, Ianni BM, Bellotti G, Pileggi F: Male sex. Prognostic factor in Chagas’ disease. Arq Bras Cardiol. 1993, 60 (4): 225-227.
    Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzman S, Moreno Barral J, Caeiro TF, Madoery RJ, Salomone OA: Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart. 2003, 89 (10): 1186-1190. 10.1136/heart.89.10.1186.
    Florez O, Martin J, Gonzalez CI: Genetic variants in the chemokines and chemokine receptors in Chagas disease. Hum Immunol. 2012, 73 (8): 852-858. 10.1016/j.humimm.2012.04.005.
    Marino AP, da Silva A, dos Santos P, Pinto LM, Gazzinelli RT, Teixeira MM, Lannes-Vieira J: Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation. 2004, 110 (11): 1443-1449. 10.1161/01.CIR.0000141561.15939.EC.
    Medeiros GA, Silverio JC, Marino AP, Roffe E, Vieira V, Kroll-Palhares K, Carvalho CE, Silva AA, Teixeira MM, Lannes-Vieira J: Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage. Microbes Infect. 2009, 11 (2): 264-273. 10.1016/j.micinf.2008.11.012.
    Marino AP, Silva AA, Santos PV, Pinto LM, Gazinelli RT, Teixeira MM, Lannes-Vieira J: CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis. Mem Inst Oswaldo Cruz. 2005, 100 (Suppl 1): 93-96.